The Central Drugs Standard Control Organization vide notice dated 21 September 2020 has issued guidelines in consideration with WHO, USFDA and EMA guidelines for development of Covid-19 vaccinations. The guidelines are not binding and does not override any existing statutory requirements, but is recommendatory in nature. Any objections or comments shall be forwarded to dci@nic.in within 12 October 2020.
Correction In Price Issued For Synchrobreathe Inhaler
The price of the Synchrobreathe Inhaler for Budesonide Inhalation (MDI) 200 mcg/dose for 200 doses has therefore been revised to correct a typographical error. It